The Patent Trial and Appeal Board Again Survives Supreme Court Review
For the generic drug and biosimilar industries, the Supreme Court’s recent decision in United States v. Arthrex, Inc. comes as a relief.
Patent Law
-
Read more: The Patent Trial and Appeal Board Again Survives Supreme Court Review -
Read more: The Patent Trial and Appeal Board Returns to the Supreme Court The Patent Trial and Appeal Board Returns to the Supreme Court
How the Court decides United States v. Arthrex will have important implications for patent law and for administrative law more generally.
-
Read more: 3 Challenges to Patents on Therapeutic Monoclonal Antibodies 3 Challenges to Patents on Therapeutic Monoclonal Antibodies
Three developments may have effects on the use of patents to fend off competition for therapeutic monoclonal antibodies.
-
Read more: AbbVie Wins First Round in Humira Antitrust Lawsuit AbbVie Wins First Round in Humira Antitrust Lawsuit
The purpose of the secondary patent filings was to assemble a thicket of patents, 132 in all, to prohibit competition from biosimilar companies.
-
Read more: Clash of Titans? A Brewing Dispute between Telehealth Giants Clash of Titans? A Brewing Dispute between Telehealth Giants
Competition between telehealth providers spilled into open conflict last month, as incumbent Teladoc filed a patent infringement suit against Amwell.
-
Read more: Compulsory Licensing for Pharmaceuticals in the EU: A Reality Check Compulsory Licensing for Pharmaceuticals in the EU: A Reality Check
To secure widespread access to a COVID-19 vaccine, many countries plan to seek refuge in a long-existing strategy: compulsory licensing.
-
Read more: Deconstructing Moderna’s COVID-19 Patent Pledge Deconstructing Moderna’s COVID-19 Patent Pledge
In the high-stakes market for COVID-19 vaccines, it is worth considering what motivates a private firm to relinquish valuable IP rights.
-
Read more: To Cut Prescription Drug Spending, Stop Delays for Generic Competition To Cut Prescription Drug Spending, Stop Delays for Generic Competition
While generic competition is crucial for reducing drug prices, brand-name drug manufacturers can utilize several strategies to delay such competition.
-
Read more: Patent Fakes: How Fraudulent Inventions Threaten Public Health, Innovation, and the Economy Patent Fakes: How Fraudulent Inventions Threaten Public Health, Innovation, and the Economy
What if you have a great idea for a new technology, but never actually create it, test it, or determine that it works? Is that patentable?
-
Read more: COVID-19 Highlights Need for Rights to Repair and Produce in Emergencies COVID-19 Highlights Need for Rights to Repair and Produce in Emergencies
The pandemic makes a stronger case for the need to explicitly incorporate into our legal system a right to repair and supply products in emergencies.
